SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
1.220
-0.020 (-1.61%)
At close: Nov 21, 2024, 4:00 PM
1.230
+0.010 (0.82%)
After-hours: Nov 21, 2024, 5:17 PM EST
SLS Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 78 | 34 | 49 | 88 | 55 | 21 | |
| Market Cap Growth | 72.97% | -30.05% | -44.69% | 59.80% | 162.42% | -22.68% | |
| Enterprise Value | 59 | 31 | 28 | 62 | 48 | 12 | |
| Last Close Price | 1.24 | 1.06 | 2.36 | 5.53 | 5.81 | 4.30 | |
| PS Ratio | - | - | 48.59 | 11.56 | 28.93 | - | |
| PB Ratio | 5.02 | -4.26 | 10.02 | 4.32 | 1.97 | 3.44 | |
| P/TBV Ratio | 5.75 | - | 16.54 | 4.77 | 2.70 | - | |
| EV/Sales Ratio | - | - | 28.28 | 8.21 | 25.15 | - | |
| Debt / Equity Ratio | 0.04 | -0.11 | 0.19 | 0.04 | 0.04 | 0.04 | |
| Asset Turnover | - | - | 0.04 | 0.21 | 0.06 | - | |
| Quick Ratio | 1.98 | 0.18 | 1.10 | 4.29 | 2.86 | 1.43 | |
| Current Ratio | 2.26 | 0.23 | 1.14 | 4.63 | 2.99 | 1.56 | |
| Return on Equity (ROE) | -535.10% | - | -327.81% | -85.70% | -98.41% | -340.31% | |
| Return on Assets (ROA) | -118.43% | -174.27% | -84.58% | -33.86% | -33.88% | -64.16% | |
| Return on Capital (ROIC) | -308.36% | - | -148.19% | -48.88% | -60.20% | -186.15% | |
| Earnings Yield | -41.30% | -109.87% | -85.00% | -23.56% | -30.48% | -92.09% | |
| FCF Yield | -42.31% | -92.42% | -49.00% | -29.62% | -18.95% | -84.22% | |
| Buyback Yield / Dilution | -99.45% | -43.21% | -25.29% | -94.07% | -211.76% | -878.33% | |
| Total Shareholder Return | -99.45% | -43.21% | -25.29% | -94.07% | -211.76% | -878.33% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.